370PDPhase I dose escalation study of M2698, a p70S6K/AKT inhibitor, in patients with advanced cancer
Tsimberidou, A.M., Verschraegen, C., Weise, A., Sarantopoulos, J., Lopes, G., Nemunaitis, J., Victor, A., Shaw, J., Kaleta, R., Kurzrock, R.Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx367.004
Date:
September, 2017
File:
PDF, 96 KB
english, 2017